Loading organizations...

§ Private Profile · Homeruslaan 4 A Zeist, UT 3707 GS Netherlands
Generative AI platform for healthcare, enabling AI tool development and integration to streamline workflows and reduce administrative tasks.
HealthSage AI develops an open, secure generative AI platform for healthcare, enabling the creation, customization, and integration of AI tools to streamline workflows and reduce administrative tasks, based in Amsterdam, Netherlands. The company's large language model converts unstructured clinical notes into FHIR format, supporting better data exchange, summaries, and patient care. In April 2024, HealthSage AI closed an oversubscribed €3M pre-seed/seed funding round led by Peak, with participation from Healthy.Capital and Rubio Impact Ventures, among others including Jaap Maljers and Jeroen Tas. The platform currently serves approximately 40,000 users and maintains a team of 11 to 20 employees. Its technology invites developers to build compliant AI applications such as discharge letters and clinical decision aids, emphasizing EU AI regulation compliance. HealthSage AI was founded in 2023 by serial entrepreneur Harm-Jan Wessels and Marcel Alberti.
HealthSage AI has raised $3.0M across 1 funding round.
HealthSage AI has raised $3.0M in total across 1 funding round.
# HealthSage AI: Transforming Healthcare Through Open Generative AI
HealthSage AI is a healthcare-focused generative AI platform company that develops large language models and AI applications specifically designed for the healthcare sector[1][3]. The company builds an open, vendor-neutral platform that enables healthcare providers, organizations, and patients to integrate AI into their systems while maintaining compliance, safety, and responsible innovation[1][2].
The platform addresses a critical pain point in healthcare: administrative burden. Healthcare professionals spend up to 40% of their time on information chasing and clerical tasks[6]. HealthSage AI solves this by offering AI-powered applications that automate administrative duties (such as discharge letter creation), support clinical decision-making, simplify problem list management, and transform complex clinical notes into patient-friendly language[2][3][5].
HealthSage AI was founded in 2023 by Harm-Jan Wessels (CEO) and Marcel Alberti (COO), both serial entrepreneurs with deep healthcare and software expertise[2][6]. Wessels previously built two international healthcare businesses—Applicare (acquired by General Electric) and Forcare (acquired by Philips)—while Alberti brings expertise in digital transformation[2]. This founding team recognized that generative AI represented "the biggest technology shift" in healthcare and positioned the company to help professionals redirect their focus from administrative work to patient care[6].
The company launched its first flagship product, Note-to-FHIR, on December 1, 2023—a specialized large language model that transforms unstructured medical notes into structured FHIR (Fast Healthcare Interoperability Resources) output, the global standard for electronic healthcare information exchange[5]. This early product demonstrated immediate traction, with HealthSage securing a €3 million seed investment in April 2024, led by Peak Capital with co-investments from Healthy.Capital, Rubio Impact Ventures, and healthcare entrepreneurs[5][6].
HealthSage AI operates at the intersection of two powerful trends: the explosion of generative AI capabilities and the acute staffing and efficiency crisis in healthcare. The timing is critical—healthcare systems globally face mounting administrative burden, clinician burnout, and pressure to improve care quality while controlling costs[6].
The company's open-source approach challenges the dominant closed-model paradigm in enterprise AI. By building a vendor-neutral platform, HealthSage AI positions itself as infrastructure for the healthcare AI ecosystem rather than a single-solution vendor. This model aligns with broader industry movement toward interoperability and data portability in healthcare IT[3].
HealthSage AI also represents a shift toward domain-specific AI models. Rather than applying general-purpose large language models to healthcare, the company demonstrates that specialized training on medical data, validated by healthcare professionals, delivers superior performance. This validates a broader thesis that vertical AI solutions outperform horizontal ones in regulated, specialized domains[4].
HealthSage AI is well-positioned to capture significant value as healthcare systems accelerate AI adoption. The €3 million seed funding enables the company to expand its team, commercialize additional applications, and scale customer deployments[6]. Early validation comes from partnerships like the "Smart Problem List" developed with healthcare institutions, which demonstrates real-world clinical impact[3].
The company's future trajectory will likely depend on three factors: (1) expanding its application suite beyond initial use cases, (2) achieving regulatory approvals and certifications across major healthcare markets, and (3) building network effects through its open-source community. As healthcare organizations increasingly recognize that compliance and safety are non-negotiable in AI adoption, HealthSage AI's regulatory-first approach and healthcare-professional validation become competitive advantages rather than constraints.
In a healthcare AI landscape crowded with general-purpose models, HealthSage AI's bet on open, specialized, and compliant AI infrastructure addresses a genuine market need—and one that will only grow as healthcare systems move from AI pilots to production deployments.
HealthSage AI has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in April 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2024 | $3M Seed | Peak | Jonathan Becker, Jaap Maljers, Jeroen TAS, Healthy.capital, Rubio Impact Ventures | Announced |
HealthSage AI has raised $3.0M in total across 1 funding round.
HealthSage AI's investors include Peak, Jonathan Becker, Jaap Maljers, Jeroen Tas, Healthy.Capital, Rubio Impact Ventures.